Lv0
0 积分 2026-08-07 加入
Finerenone: a game changer for chronic kidney disease patients with type 2 diabetes
12天前
已完结
Reply
12天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
12天前
已完结
Finerenone in Chinese Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELITY Subgroup Analysis
16天前
已完结
Real-World Impact of Finerenone on Albuminuria in Patients with Diabetes and CKD
22天前
已完结
Tackling chronic kidney disease in diabetic patients with finerenone
22天前
已完结
Real-world analysis of the impact of finerenone on estimated glomerular filtration rate and albuminuria in patients with diabetic kidney disease
22天前
已完结
Review of Hyperkalemia Profile for Mineralocorticoid Receptor Antagonist in Patients with Chronic Kidney Disease and Type 2 Diabetes
22天前
已完结
Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results
1个月前
已完结
Association of finerenone with prognosis and safety in diabetic kidney disease patients: an undated meta-analysis based on four RCTs
1个月前
已完结
皖公网安备34019202002308
